Great collaborative study from @lymphomatic, @DrAEvens & many others. International validation of the Burkitt lymphoma IPI. Important work defining high risk features (Age >40, LDH >3xULN, CNS disease, PS 2+). Crucial for future stratified trials.
#lymsmascopubs.org/doi/abs/10.1200…